- Clinical Assistant Professor, CWRU School of Medicine
- Actinic Keratosis
- Basal Cell Carcinoma
- Dermatologic Surgery
- Mohs Micrographic Surgery
- Non-Melanoma Skin Cancers
- Squamous Cell Carcinoma
- Transplant Dermatology
Patient Experience Reviews
4.9 out of 5
Patient Comments (9)
Reviewed On 6/1/2020
Always very friendly and professional
Reviewed On 3/2/2020
Dr. Bahner was very professional and showed concern for my needed care. She was very kind and cosiderate during my surgery. I felt at ease and comfortable under her care.
Reviewed On 3/1/2020
dr. bahner is very thorough and easy to talk to. ***, the nurse, is organized and personable. I appreciated both of them. thanks!
Reviewed On 2/28/2020
Great experience. Doctor was excellent and so was her MA.
Reviewed On 2/15/2020
Dr. Bahner and her staff always treat me with courtesy and friendliness. I have a number of derm issues, and she always answers my questions, treats when necessary, and always reassures me about issues that don't need treatment.
Reviewed On 2/9/2020
Doctor Bahner is fantastic!
Reviewed On 2/7/2020
Reviewed On 2/7/2020
Dr Bahner removed a carcinoma from my back. This was the third time she has done this. Each time she has been professional, courteous, and concerned. I could not ask for a better experience, in light of what needed to be done.
Reviewed On 2/2/2020
Dr. Bahner and staff worked hard to accommodate my requirement of using an outside lab, which is covered by my insurance. Thank God! I couldn't afford the tests without them going the extra mile!
- Dermatology - American Board of Dermatology
Fellowship | Micrographic Surgery and Dermatologic Oncology
Micrographic Surgery and Dermatologic Oncology - Cleveland Clinic (2013 - 2014)
Residency | Dermatology
Dermatology - Uh Case Medical Center (2010 - 2013)
Research Fellowship | Dermatology
Dermatology - Uh Case Medical Center (2007 - 2010)
Internship | Internal Medicine
Internal Medicine - Uh Case Medical Center (2006 - 2007)
University Of Wisconsin School Of Medicine And Public Health (2006)
University Of Michigan (2001)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Jennifer Bahner did not disclose any Outside Relationships with Industry.